留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

中国肝移植免疫抑制治疗与排斥反应诊疗规范(2019版)

中华医学会器官移植学分会

中华医学会器官移植学分会. 中国肝移植免疫抑制治疗与排斥反应诊疗规范(2019版)[J]. 器官移植, 2021, 12(1): 8-14, 28. doi: 10.3969/j.issn.1674-7445.2021.01.002
引用本文: 中华医学会器官移植学分会. 中国肝移植免疫抑制治疗与排斥反应诊疗规范(2019版)[J]. 器官移植, 2021, 12(1): 8-14, 28. doi: 10.3969/j.issn.1674-7445.2021.01.002
Branch of Organ Transplantation of Chinese Medical Association. Diagnosis and treatment specification for immunosuppressive therapy and rejection of liver transplantation in China (2019 edition)[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 8-14, 28. doi: 10.3969/j.issn.1674-7445.2021.01.002
Citation: Branch of Organ Transplantation of Chinese Medical Association. Diagnosis and treatment specification for immunosuppressive therapy and rejection of liver transplantation in China (2019 edition)[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 8-14, 28. doi: 10.3969/j.issn.1674-7445.2021.01.002

中国肝移植免疫抑制治疗与排斥反应诊疗规范(2019版)

doi: 10.3969/j.issn.1674-7445.2021.01.002
详细信息
    通讯作者:

    陶开山,Email:taokaishan0686@163.com

  • 中图分类号: R617, R392.4

Diagnosis and treatment specification for immunosuppressive therapy and rejection of liver transplantation in China (2019 edition)

More Information
  • 摘要: 肝脏虽为“免疫特惠器官”,肝移植术后急性排斥反应发生率及严重程度明显低于其他器官移植,但术后排斥反应仍较为常见,规范的免疫抑制治疗是保证移植效果的关键。为进一步规范肝移植术后免疫抑制治疗及排斥反应诊疗,中华医学会器官移植学分会组织肝移植专家,总结国内外相关研究最新进展,并结合国际指南和临床实践,针对肝移植术后免疫抑制剂应用原则、常用方案及各类型排斥反应的诊断与治疗,制订《中国肝移植免疫抑制治疗与排斥反应诊疗规范(2019版)》。

     

  • [1] HALLIDAY N, WESTBROOK RH. Liver transplantation: post-transplant management[J]. Br J Hosp Med (Lond), 2017, 78(5):278-285. DOI: 10.12968/hmed.2017.78.5.278.
    [2] SHAKED A, DESMARAIS MR, KOPETSKIE H, et al. Outcomes of immunosuppression minimization and withdrawal early after liver transplantation[J]. Am J Transplant, 2019, 19(5):1397-1409. DOI: 10.1111/ajt.15205.
    [3] JUCAUD V, SHAKED A, DESMARAIS M, et al. Prevalence and impact of de novo donor-specific antibodies during a multicenter immunosuppression withdrawal trial in adult liver transplant recipients[J]. Hepatology, 2019, 69(3):1273-1286. DOI: 10.1002/hep.30281.
    [4] GUO T, LEI J, GAO J, et al. The hepatic protective effects of tacrolimus as a rinse solution in liver transplantation: a Meta-analysis[J]. Medicine (Baltimore), 2019, 98(21): e15809. DOI: 10.1097/MD.0000000000015809.
    [5] RAYAR M, TRON C, LOCHER C, et al. Tacrolimus concentrations measured in excreted bile in liver transplant recipients: the STABILE study[J]. Clin Ther, 2018, 40(12):2088-2098. DOI: 10.1016/j.clinthera. 2018.10.015.
    [6] SALIBA F, ROSTAING L, GUGENHEIM J, et al. Corticosteroid-sparing and optimization of mycophenolic acid exposure in liver transplant recipients receiving mycophenolate mofetil and tacrolimus: a randomized, multicenter study[J]. Transplantation, 2016, 100(8):1705-1713. DOI: 10.1097/TP.0000000000001228.
    [7] GRIGG SE, SARRI GL, GOW PJ, et al. Systematic review with Meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma[J]. Aliment Pharmacol Ther, 2019, 49(10):1260-1273. DOI: 10.1111/apt.15253.
    [8] JUNG DH, TAK E, HWANG S, et al. Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence[J]. Liver Transpl, 2018, 24(7):932-945. DOI: 10.1002/lt.25191.
    [9] PERITO ER, MARTINEZ M, TURMELLE YP, et al. Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials[J]. Am J Transplant, 2019, 19(5):1545-1551. DOI: 10.1111/ajt.15255.
    [10] CASTEDAL M, SKOGLUND C, AXELSON C, et al. Steroid-free immunosuppression with low-dose tacrolimus is safe and significantly reduces the incidence of new-onset diabetes mellitus following liver transplantation[J]. Scand J Gastroenterol, 2018, 53(6):741-747. DOI: 10.1080/00365521.2018.1463390.
    [11] KOO J, WANG HL. Acute, chronic, and humoral rejection: pathologic features under current immunosuppressive regimes[J]. Surg Pathol Clin, 2018, 11(2):431-452. DOI: 10.1016/j.path.2018.02.011.
    [12] AIBARA N, OHYAMA K, HIDAKA M, et al. Immune complexome analysis of antigens in circulating immune complexes from patients with acute cellular rejection after living donor liver transplantation[J]. Transpl Immunol, 2018, 48:60-64. DOI: 10.1016/j.trim.2018.02.011.
    [13] LO RC, CHAN KK, LEUNG CO, et al. Expression of hepatic progenitor cell markers in acute cellular rejection of liver allografts-an immunohistochemical study[J]. Clin Transplant, 2018, 32(3):e13203. DOI: 10.1111/ctr.13203.
    [14] LEE M. Antibody-mediated rejection after liver transplant[J]. Gastroenterol Clin North Am, 2017, 46(2): 297-309. DOI: 10.1016/j.gtc.2017.01.005.
    [15] RODRÍGUEZ-PERÁLVAREZ M, RICO-JURI JM, TSOCHATZIS E, et al. Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal[J]. Transpl Int, 2016, 29(9):961-973. DOI: 10.1111/tri.12737.
    [16] MCALISTER VC. Anti-donor immunoglobulin G subclass in liver transplantation[J]. Hepatobiliary Surg Nutr, 2019, 8(2):125-128. DOI: 10.21037/hbsn.2018.12.09.
    [17] JADLOWIEC CC, TANER T. Liver transplantation: current status and challenges[J]. World J Gastroenterol, 2016, 22(18):4438-4445. DOI: 10.3748/wjg.v22.i18.4438.
    [18] FENG S, BUCUVALAS JC, DEMETRIS AJ, et al. Evidence of chronic allograft injury in liver biopsies from long-term pediatric recipients of liver transplants[J]. Gastroenterology, 2018, 155(6):1838-1851. DOI: 10.1053/j.gastro.2018.08.023.
    [19] BITAR C, OLIVIER K, LEE C, et al. Acute graft-vs-host disease following liver transplantation[J]. Cutis, 2019, 103(6):E8-E11.
    [20] 马明, 蒋文涛.肝移植术后移植物抗宿主病[J/CD].实用器官移植电子杂志, 2014, 2(4): 249-252. DOI: 10.3969/j.issn.2095-5332.2014.04.012.

    MA M, JIANG WT. Graft versus host disease after liver transplantation[J/CD]. Prac J Organ Transplant(Electr Vers), 2014, (4): 249-252. DOI: 10.3969/j.issn.2095-5332.2014.04.012.
  • 加载中
计量
  • 文章访问数:  133
  • HTML全文浏览量:  48
  • PDF下载量:  49
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-11-18
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2021-01-19

目录

    /

    返回文章
    返回